Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration - Top-Institutions - MDSpire

Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration

  • By

  • Takaaki Matsuki

  • Kunihiko Akiyama

  • Ken Watanabe

  • Toru Noda

  • Mariko Sasaki

  • July 15, 2026

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    National Hospital Organization Tokyo Medical Center
    National Hospital Organization Tokyo Medical Center

    Tokyo, Tokyo

    Key Differentiators

    • Ophthalmology

  • #2

    The New York Eye and Ear Infirmary
    The New York Eye and Ear Infirmary

    New York, NY

    Key Differentiators

    • Ophthalmology

  • #3

    National Eye Institute
    National Eye Institute

    Bethesda, MD

    Key Differentiators

    • Ophthalmology

  • #4

    Department of Veteran Affairs
    Department of Veteran Affairs

    Washington, DC

    Key Differentiators

    • Ophthalmology

Original Source(s)

Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration

  • by Takaaki Matsuki, Kunihiko Akiyama, Ken Watanabe, Toru Noda, Mariko Sasaki

  • July 15, 2026

Related Content

Oculomotor markers of functional impairment in traumatic brain injury using simple and predictive visual tracking

Differential tear metabolomics in blepharokeratoconjunctivitis and herpes simplex keratitis: potential biomarkers for clinical differentiation

Vision Screening and Vision Loss–Related Conditions Among American Indian or Alaska Native Children